Al-Mousa, Hamoud <br/><br/>
Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Jun 2010 
 - 818-23 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2010.01.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Cell Count<br/>Bone Marrow Transplantation--adverse effects<br/>Child<br/>Child, Preschool<br/>Disease-Free Survival<br/>Female<br/>Graft Survival--immunology<br/>Graft vs Host Disease--diagnosis<br/>HLA Antigens--immunology<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Histocompatibility--immunology<br/>Histocompatibility Antigens Class II<br/>Humans<br/>Immunoglobulin G--blood<br/>Immunologic Deficiency Syndromes--immunology<br/>Infant<br/>Infant, Newborn<br/>Lymphocyte Count<br/>Lymphocytes--cytology<br/>Male<br/>Myeloablative Agonists--therapeutic use<br/>Retrospective Studies<br/>Transplantation Chimera--immunology<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Treatment Outcome